Mildred Moss

Mildred Moss supports the National Institute of Allergy and Infectious Diseases (NIAID) in managing critical procurement activities aligned with the agency’s mission to advance biomedical research for infectious, immunologic, and allergic disease threats. She oversees acquisitions for specialized laboratory infrastructure, biosafety equipment, and diagnostic development tools, ensuring compliance with federal contracting regulations and strategic priorities in public health preparedness. Her portfolio emphasizes high-containment research capabilities and technical services essential to NIAID’s response to emerging pathogens, with a focus on maintaining operational readiness through reliable, mission-critical supply chains. Moss maintains a primary contracting relationship with Quality Biological, Inc., a key provider of biological reference materials and specialized reagents essential for infectious disease research. She also engages with GENOMIC LABS LTD and other niche vendors to secure precision instrumentation, biocontainment components, and analytical support services. Her procurement approach prioritizes technical specificity over volume, fostering long-term partnerships with vendors capable of meeting stringent biosafety and quality control standards required in BSL-3 and BSL-4 environments. While the majority of her acquisitions—84.6%—are conducted as full and open competitions, she consistently allocates 15.4% of awards to total small business set-asides under FAR 19.5, reflecting a deliberate commitment to expanding small business participation in high-tech biomedical procurement. Her socioeconomic contracting patterns prioritize qualified small businesses with demonstrated expertise in specialized manufacturing and laboratory support services. Her procurement focus is heavily concentrated in NAICS 811210 for electronic and precision equipment repair and maintenance, underscoring her role in sustaining advanced laboratory instrumentation. She also procures industrial gases and biological products under NAICS 325120 and 325414, respectively, demonstrating technical fluency in biosafety supply chains and diagnostic development ecosystems. Her expertise lies at the intersection of laboratory operations, biocontainment infrastructure, and regulated biological manufacturing.